Keyphrases
China
100%
Clinical Significance
100%
Hefei
100%
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
100%
C(T)
25%
Synonymous mutation
25%
Immune Response
12%
Virus
12%
South-East Asia
12%
Inflammatory Cytokines
12%
Quantitative PCR
12%
Single nucleotide Polymorphism
12%
Clinical Samples
12%
Global Public Health
12%
GenBank
12%
East Asia
12%
Clinical Investigation
12%
Affiliated Hospitals
12%
Variable Site
12%
Whole Genome Sequencing
12%
Phylogenetic Network Analysis
12%
Confirmed Cases
12%
Mutation Sites
12%
Cytokine Profile
12%
Anhui
12%
S-type
12%
Genomic Surveillance
12%
COVID-19 Pandemic
12%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
12%
Medical University
12%
Shared Variables
12%
ORF1b
12%
Public Economy
12%
Anhui Province
12%
Yangtze River Delta Region
12%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
57%
Immune Response
14%
Infectious Agent
14%
Lifespan
14%
Inflammatory Cytokine
14%
Reverse Transcription Polymerase Chain Reaction
14%
Single Nucleotide Polymorphism
14%
Phylogeny
14%
Whole Genome Sequencing
14%
GenBank
14%
Genomic Surveillance
14%
Cladistics
14%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Coronavirinae
57%
Immune Response
14%
Lifespan
14%
Phylogeny
14%
Infectious Agent
14%
Single-Nucleotide Polymorphism
14%
Reverse Transcription Polymerase Chain Reaction
14%
GenBank
14%
Inflammatory Cytokine
14%
Whole Genome Sequencing
14%
Genomics
14%
Cladistics
14%
Neuroscience
SARS Coronavirus
100%
Coronavirus
57%
Coronavirinae
57%
Phylogenetics
14%
Single-Nucleotide Polymorphism
14%
Whole Genome Sequencing
14%